Simon Schwartz Navarro Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools. Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services LinkedIn Twitter Orcid Email Simon Schwartz Navarro LinkedIn Twitter Orcid Email Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools.
Currently acting as Strategy director of biobanking and bioresources at Vall d'hebron Campus. President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine. Former director general of the Blood and Tissue Banc of Catalonia. Former director of CIBBIM-Nanomedicine. Former scientific associate director of CIBER-BBN and coordinator of technology transfer. Former director assistance of translational research at VHIR. H-index of 40, with more that 115 high impact publications and 17 transferred patents. Co-founder of 3 biotech companies (i.e, Bsure Medical ltd). Science Advisor of the European Nanomedicine Characterization Laboratory (EU-NCL). Member of the editorial Board of Precision Nanomedicine, J. Nanotechnology and of J. of Nanotheranostics. Former editorial Board member of Eur. J. Nanomedicine and Nanomedicine-NBM.
Projects Innovative Training Network (ITN) in Nanomedicine (NANO2EXCEL) IP: Simon Schwartz Navarro Collaborators: - Funding agency: Ministerio Economía, Industria y Competitividad Funding: 23000 Reference: EUIN2013-51211 Duration: 01/10/2013 - 30/09/2015 Liberación dirigida de nanoconjugados de inhibidor de Alox5 contra células madre tumorales IP: Simon Schwartz Navarro Collaborators: Laura García Latorre, Diana Fernandes de Rafael Funding agency: Instituto de Salud Carlos III Funding: 171215 Reference: PI14/02079 Duration: 01/01/2015 - 31/12/2017 Sistemas de liberación farmacológica dirigidos contra células madre tumorales- prueba de concepto IP: Simon Schwartz Navarro Collaborators: Joaquin Seras Franzoso, Miriam Izquierdo Sans Funding agency: Asociación Española Contra el Cáncer Funding: 135000 Reference: 2014/AECC-AIO/SERAS Duration: 01/02/2015 - 31/01/2020 Targetting Combined Therapy to Cancer Stem Cells (NANOSTEM) IP: Simon Schwartz Navarro Collaborators: Laura García Latorre Funding agency: Instituto de Salud Carlos III Funding: 145540.01 Reference: PI11/01079 Duration: 01/01/2012 - 31/12/2014 Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 … Next page › Last page »
